Keyphrases
Multiple Sclerosis
100%
Ex Vivo Studies
100%
Early Identification
100%
Interferon-β (IFN-β)
100%
Interleukin-10
71%
Interferon-β Treatment
57%
Interleukin-5 (IL-5)
42%
Serum Cytokine Level
42%
Multiple Sclerosis Treatment
28%
Positive Predictive Value
28%
Negative Predictive Value
28%
Clinical Response
28%
Effective Treatment
14%
Serum Levels
14%
Predictive Marker
14%
Predictive Power
14%
Mechanism of Action
14%
Treatment Response
14%
Interleukin-4 (IL-4)
14%
Interleukin-13 (IL-13)
14%
Monocytes
14%
Relapsing-remitting multiple Sclerosis
14%
Correlated Change
14%
Patient Self-testing
14%
Treatment Responder
14%
Treatment Considerations
14%
Co-signaling Molecules
14%
Combined Test
14%
Longitudinal Measurement
14%
Pathophysiological Basis
14%
Immunology and Microbiology
Multiple Sclerosis
100%
Beta Interferon
100%
Interleukin 10
45%
Cytokine
27%
Interleukin 5
27%
Relapsing Remitting Multiple Sclerosis
9%
Blood Level
9%
ELISA
9%
Upregulation
9%
Interleukin 13
9%
Interleukin 4
9%
Neuroscience
Multiple Sclerosis
100%
Beta Interferon
100%
Interleukin 10
45%
Interleukin 5
27%
ELISA
9%
Relapsing Remitting Multiple Sclerosis
9%
Interleukin 13
9%
Interleukin 4
9%